Last $0.11 USD
Change Today 0.00 / 0.00%
Volume 70.8K
VNTH On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

vantage health (VNTH) Snapshot

Open
$0.11
Previous Close
$0.11
Day High
$0.11
Day Low
$0.11
52 Week High
06/20/14 - $0.35
52 Week Low
10/29/13 - $0.0022
Market Cap
21.1M
Average Volume 10 Days
55.6K
EPS TTM
--
Shares Outstanding
192.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VANTAGE HEALTH (VNTH)

Related News

No related news articles were found.

vantage health (VNTH) Related Businessweek News

No Related Businessweek News Found

vantage health (VNTH) Details

Vantage Health Inc. operates as a mobile healthcare technology company in the United States. It is involved in developing personalized and point-of-care screening using applications based upon chemical sensing residing in a small device attached to a smartphone. The company provides the Vantage Health Sensor, a convergence of nano-electronics, bio-informatics, and wireless technology that create mobile health applications. It has a strategic partnership with Scripps Translational Sciences Institute to assist in the development, advancement, and commercialization of the mobile technology. The company was incorporated in 2010 and is based in Redwood City, California. Vantage Health Inc. operates as a subsidiary of Nanobeak, Inc.

12 Employees
Last Reported Date: 10/15/14
Founded in 2010

vantage health (VNTH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

vantage health (VNTH) Key Developments

Vantage Health Inc. Auditor Raises 'Going Concern' Doubt

Vantage Health Inc. filed its 10-K on Oct 14, 2014 for the period ending Jun 30, 2014. In this report its auditor, Malone & Bailey, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Vantage Health Inc. Appoints Tony Van Bijleveld as an Independent Member of Board of Directors

Vantage Health has appointed Tony van Bijleveld as an independent member of the Board of Directors of company. Van Bijleveld is currently General Manager with drug manufacturer Patheon/DPX. Over the past 30 years he has served in a variety of senior executive capacities in the pharmaceutical and biotech industry including: Managing Director of United Drug PLC, President/General Manager Russia for Schering Plough/MSD, SVP of Organon Biosciences, and Managing Director of KCL Foundation Labs.

Vantage Health Inc. Appoints Edward Rollins to Board of Directors

Vantage Health Inc. announced the appointment of Edward Rollins to its Board of Directors. Mr. Rollins currently serves as a senior advisor for Teneo. Mr. Rollins is an internationally renowned public and corporate relations strategist and well-known political commentator. He has appeared on CNN, Meet the Press, Face the Nation, and many other major network news stations and talk shows. He has advised Fortune 400 chief executives and leaders of major trade associations on corporate reputation, crisis management, advertising, public relations, and governmental affairs. In addition to his role at Teneo, Mr. Rollins is the senior presidential fellow at Hofstra University's Center for the Study of the American Presidency in New York, and works for Fox News as a senior political analyst.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNTH:US $0.11 USD 0.00

VNTH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VNTH.
View Industry Companies
 

Industry Analysis

VNTH

Industry Average

Valuation VNTH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VANTAGE HEALTH, please visit www.vantagehealthinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.